These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 21406497

  • 21. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [Abstract] [Full Text] [Related]

  • 22. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN.
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [Abstract] [Full Text] [Related]

  • 23. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
    Fernández M, Calvo-Alén J, Alarcón GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G, Vilá LM, Sanchez ML, Reveille JD.
    Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
    [Abstract] [Full Text] [Related]

  • 24. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 25. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
    Aghdassi E, Ma DW, Morrison S, Hillyer LM, Clarke S, Gladman DD, Urowitz MB, Fortin PR.
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):198-208. PubMed ID: 21378249
    [Abstract] [Full Text] [Related]

  • 26. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 27. [Cardiovascular risk profile in a Portuguese cohort of SLE Portuguese patients].
    Duarte C, Couto M, Vaz C, Inês L, Malcata A.
    Acta Reumatol Port; 2009 May; 34(2B):349-57. PubMed ID: 19727047
    [Abstract] [Full Text] [Related]

  • 28. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
    Koca SS, Karaca I, Yavuzkir MF, Dağli N, Ozgen M, Ustündağ B, Işik A.
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
    [Abstract] [Full Text] [Related]

  • 29. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A, Cheung BM, Mok CC, Leung R, Lau CS.
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [Abstract] [Full Text] [Related]

  • 30. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
    Lalani S, Pope J, de Leon F, Peschken C, Members of CaNIOS/1000 Faces of Lupus.
    J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
    [Abstract] [Full Text] [Related]

  • 31. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF.
    Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188
    [Abstract] [Full Text] [Related]

  • 32. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.
    Rahman P, Urowitz MB, Gladman DD, Bruce IN, Genest J.
    J Rheumatol; 1999 Nov 15; 26(11):2363-8. PubMed ID: 10555892
    [Abstract] [Full Text] [Related]

  • 33. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C, Jönsen A, Nived O, Sturfelt G.
    J Rheumatol; 2000 Mar 15; 27(3):685-91. PubMed ID: 10743809
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL.
    Arthritis Rheum; 2005 Jan 15; 52(1):192-200. PubMed ID: 15641060
    [Abstract] [Full Text] [Related]

  • 38. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
    Tso TK, Huang WN, Huang HY, Chang CK.
    Rheumatology (Oxford); 2006 Sep 15; 45(9):1148-53. PubMed ID: 16527878
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K.
    J Rheumatol; 2004 Nov 15; 31(11):2156-62. PubMed ID: 15517627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.